Trial Profile
A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension [EXTENSION OF 700243056]
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Nitrite (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- Sponsors Aires Pharmaceuticals
- 28 Apr 2014 New trial record
- 08 Apr 2014 Status changed from recruiting to discontinued, according to ClinicalTrials.gov.